Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
Sponsored by Power Life Sciences Inc.
About this trial
Last updated 2 years ago
Study ID
72630763
Status
Not yet recruiting
Type
Observational
Placebo
No
Accepting
18+ Years
Male
Not accepting
Healthy Volunteers
Trial Timing
Started 7 months ago
What is this trial about?
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal
role in evaluating the safety and effectiveness of novel treatments for this condition.
These trials serve as essential tools to determine whether new medications outperform
traditional therapies, providing substantial evidence to endorse their broader
utilization.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of future patients
with recurrent prostate cancer.
What are the participation requirements?
Inclusion Criteria
- Patient is at least 18 years of age
- Diagnosis of recurrent prostate cancer
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with study requirements
- Inability to provide written informed consent